115 related articles for article (PubMed ID: 12324758)
1. Multiple endocrine neoplasia type 1 polymorphism D418D is associated with sporadic primary hyperparathyroidism.
Correa P; Lundgren E; Rastad J; åkerström G; Westin G; Carling T
Surgery; 2002 Sep; 132(3):450-5. PubMed ID: 12324758
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Clin Endocrinol (Oxf); 1999 May; 50(5):583-8. PubMed ID: 10468923
[TBL] [Abstract][Full Text] [Related]
3. The NeiI polymorphism in the cyclin D1 gene and sporadic primary hyperparathyroidism.
Correa P; Lundgren E; Rastad J; Akerström G; Westin G; Carling T
J Intern Med; 2001 Dec; 250(6):516-20. PubMed ID: 11902820
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
Burgess JR; David R; Greenaway TM; Parameswaran V; Shepherd JJ
Arch Surg; 1999 Oct; 134(10):1119-23. PubMed ID: 10522858
[TBL] [Abstract][Full Text] [Related]
5. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
6. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
[TBL] [Abstract][Full Text] [Related]
8. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
[TBL] [Abstract][Full Text] [Related]
9. Association between parathyroid hormone (PTH)/PTH-related peptide receptor gene polymorphism and the extent of bone mass reduction in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Horm Metab Res; 2000 Sep; 32(9):355-8. PubMed ID: 11014383
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism.
Piedra M; Berja A; Ramos L; García-Unzueta MT; Morán JM; Ruiz D; Amado JA
Endocrinol Diabetes Nutr; 2017 Dec; 64(10):524-530. PubMed ID: 29179855
[TBL] [Abstract][Full Text] [Related]
11. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism.
Hagström E; Lundgren E; Mallmin H; Rastad J; Hellman P
J Intern Med; 2006 Feb; 259(2):191-8. PubMed ID: 16420548
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels.
Correa P; Rastad J; Schwarz P; Westin G; Kindmark A; Lundgren E; Akerström G; Carling T
J Clin Endocrinol Metab; 1999 May; 84(5):1690-4. PubMed ID: 10323401
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism.
Cetani F; Borsari S; Vignali E; Pardi E; Picone A; Cianferotti L; Rossi G; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002; 25(7):614-9. PubMed ID: 12150336
[TBL] [Abstract][Full Text] [Related]
14. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.
Eller-Vainicher C; Chiodini I; Battista C; Viti R; Mascia ML; Massironi S; Peracchi M; D'Agruma L; Minisola S; Corbetta S; Cole DE; Spada A; Scillitani A
J Bone Miner Res; 2009 Aug; 24(8):1404-10. PubMed ID: 19309299
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
16. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
[TBL] [Abstract][Full Text] [Related]
17. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
Gianotti L; Tassone F; Cesario F; Pia A; Razzore P; Magro G; Piovesan A; Borretta G
J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
[TBL] [Abstract][Full Text] [Related]
18. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
20. Clinical phenotypes of Chinese primary hyperparathyroidism patients are associated with the calcium-sensing receptor gene R990G polymorphism.
Han G; Wang O; Nie M; Zhu Y; Meng X; Hu Y; Liu H; Xing X
Eur J Endocrinol; 2013 Nov; 169(5):629-38. PubMed ID: 23946278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
